BEVATEM: Phase II single-center study of bevacizumab in combination with temozolomide in patients (pts) with first-line metastatic uveal melanoma (MUM): First-step results.
Sophie Piperno-Neumann
Research Funding - Roche
Vincent Servois
No relevant relationships to disclose
Francois-Clement Bidard
No relevant relationships to disclose
Pascale Mariani
No relevant relationships to disclose
Corine Plancher
No relevant relationships to disclose
Bernard Asselain
No relevant relationships to disclose
Nora Vago-Ady
Employment or Leadership Position - Roche
Laurence Desjardins
No relevant relationships to disclose